For a patient with type 2 diabetes using insulin glargine (Lantus) 16 U daily and a rapid‑acting insulin dose of 1 U per 12 g carbohydrate, who is currently taking prednisone 15 mg in the morning and 5 mg in the evening but will switch to prednisone 15 mg only in the morning, how much should the insulin glargine dose be reduced?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Dose Adjustment for Prednisone Reduction

Do not reduce the Lantus dose when switching from prednisone 20 mg daily (15 mg AM + 5 mg PM) to 15 mg daily (15 mg AM only). In fact, you should closely monitor blood glucose levels and be prepared to increase the basal insulin dose if needed, as the patient is eliminating the evening prednisone dose which was likely contributing to overnight and morning hyperglycemia.

Rationale and Clinical Approach

The current situation involves removing only the 5 mg evening prednisone dose while maintaining the 15 mg morning dose. This is a relatively modest reduction (25% decrease in total daily prednisone), and the morning dose—which causes the most significant daytime hyperglycemia—remains unchanged.

Why Not to Reduce Lantus

Prednisone causes hyperglycemia predominantly between midday and midnight, with peak effects occurring 4-8 hours after administration 1. The 15 mg morning dose will continue to drive significant insulin resistance throughout the day. The evening 5 mg dose was likely contributing to overnight and early morning hyperglycemia, but removing it does not substantially reduce the overall insulin requirement driven by the larger morning dose.

The ADA guidelines specifically recommend considering NPH insulin in the morning for steroid-induced hyperglycemia 2, as its pharmacodynamic profile better matches the daytime hyperglycemic pattern caused by morning corticosteroids. However, since your patient is already on Lantus, the focus should be on appropriate dose management rather than switching formulations at this time.

Monitoring Strategy

  • Check fasting blood glucose daily for at least 1-2 weeks after the prednisone change
  • Monitor pre-lunch and pre-dinner glucose to assess daytime control (the period most affected by morning prednisone)
  • Watch for overnight hypoglycemia since the evening prednisone dose is being eliminated

Dose Adjustment Algorithm

  1. Week 1: Maintain Lantus at 16 units and monitor closely

    • If fasting glucose drops below 80 mg/dL on ≥2 occasions, reduce Lantus by 2 units 3
    • If fasting glucose remains >150 mg/dL consistently, increase by 2 units 3
  2. Ongoing titration: Adjust every 3-7 days based on fasting glucose patterns

    • Target fasting glucose: 90-150 mg/dL for most patients 3
    • Use 2-unit increments for adjustments 2

Prandial Insulin Considerations

The patient's rapid-acting insulin (1 unit per 12 g carbohydrate) will likely need adjustment as well. Monitor post-meal glucose levels closely, particularly after lunch and dinner when the morning prednisone effect is maximal. The carbohydrate ratio may need to be tightened (e.g., 1:10 or 1:8) during peak steroid effect hours 1.

Common Pitfalls to Avoid

  • Do not assume that a 25% reduction in prednisone requires a proportional insulin reduction—the relationship is not linear, and the morning dose drives most of the hyperglycemia
  • Avoid premature dose reduction based on a single low glucose reading; look for patterns over several days
  • Do not neglect the prandial insulin adjustments—basal insulin alone will not adequately control steroid-induced daytime hyperglycemia 1

If Further Prednisone Tapering Occurs

When the morning prednisone dose is eventually reduced below 15 mg or discontinued entirely, then more substantial basal insulin reductions will be appropriate. Research suggests that for complete steroid discontinuation, insulin requirements may decrease by 30-50% or more 1, but this should be done gradually with close monitoring to prevent both hyperglycemia and hypoglycemia.

The FDA label for Lantus emphasizes that dose adjustments should be made cautiously and only under medical supervision with appropriate glucose monitoring 4. For hypoglycemia without a clear cause, reduce the dose by 10-20% 2, 4.

Related Questions

A patient with type 2 diabetes on prednisone 40 mg at 8 am, NPH insulin 23 units (morning dose) and a carbohydrate‑to‑insulin ratio of 1 unit per 15 g carbohydrate, who consumed 132 g carbohydrate in the past 24 hours and has blood glucose readings of 246 mg/dL at 4 pm and 281 mg/dL at 8 pm, asks how the carbohydrate‑to‑insulin ratio and the NPH insulin dose should be increased.
In a 78-year-old male with an A1c of 9.1% who is prescribed 14 units of insulin glargine (Lantus) daily plus a sliding‑scale insulin, how should his insulin regimen be managed?
A patient with a usual bedtime blood glucose of about 170 mg/dL on 12–15 units of insulin glargine (Lantus) asks whether the basal insulin dose should be changed when the current bedtime glucose is 132 mg/dL; should the dose remain the same or be adjusted?
For a patient with type 2 diabetes (A1c 8.0 %, hemoglobin 8.2 g/dL, BMI 35, weight 109 kg) who received dexamethasone 20 mg yesterday, is currently on insulin glargine (Lantus) 22 U with a 1 U:8 g carbohydrate ratio and an insulin sensitivity factor of 1 U per 25 mg/dL, and has recent glucose readings of 386 mg/dL and 326 mg/dL, what should the basal insulin glargine dose be today now that dexamethasone will not be given?
For a patient with type 2 diabetes currently on insulin glargine (Lantus) 16 units daily and a 1‑unit‑per‑6‑gram carbohydrate ratio, how should the insulin dosing be adjusted during transition to palliative care and what key discussion points should be addressed?
A patient on insulin glargine (Lantus) 20 U daily and prednisone 15 mg in the morning and 10 mg in the evening with a carbohydrate‑to‑insulin ratio of 1 U per 10 g carbs will have the evening prednisone reduced to 5 mg; how should the basal insulin dose and carbohydrate‑to‑insulin ratio be adjusted?
What is the likely diagnosis and appropriate management for a 59-year-old woman with a one-year history of left knee pain, stiffness, limited flexion, difficulty climbing stairs, a positive family history of osteoarthritis, and physical exam showing diffuse pain and crepitus?
Should clopidogrel be held before performing a thoracentesis in an adult patient?
What cardiovascular monitoring strategies should be used in intubated patients, and what early signs indicate a decline in cardiac output?
What is the appropriate diagnostic work‑up and initial management for a 51‑year‑old woman with one‑month progressive lower‑extremity weakness, gait instability, hypotonia and reduced reflexes, without pain, fever, sensory loss, trauma or chronic disease?
Should immediate imaging be avoided for a 51-year-old woman with subacute symmetric progressive lower‑extremity weakness, gait instability, hypotonia, and reduced reflexes, without pain, fever, sensory loss, trauma, or known chronic disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.